Patents by Inventor Gilles Divita

Gilles Divita has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20090156503
    Abstract: The present invention concerns cell-penetrating peptides which comprise an amino acid sequence consisting of GLX9WRAX9WRX1LX2RSLX9WX3X4X5X6X7X8(SEQ ID No: 1), wherein X1 is A, L or G, X2 is W or none, X3 is R or K, X4 is K, L or S, X5 is L or K, X6 is R or W, X7 is K or S, and X8 is A, V or Q, and X9 is W, F or Y. These CPPs can be used as vectors for delivering nucleic acids and/or proteins and/or peptides to cells, in vitro or in vivo.
    Type: Application
    Filed: December 30, 2008
    Publication date: June 18, 2009
    Applicants: CENTRE NATIONAL DE LA RECHERCHE SCIENT, GENOSPECTRA, INC.
    Inventors: GILLES DIVITA, FREDERIC HEITZ, CATHERINE MAY MORRIS, GUDRUN ALDRIAN-HERRADA
  • Patent number: 7514530
    Abstract: Complex comprising a peptide carrier of SEQ ID NO:1 GALFLGFLGAAGSTMGAWSQPKR1KRKVR2 and an appropriate siRNA, wherein R1 represents any amino acid residue and more preferably K or S, R2 is null or represents one of the following groups: cysteamide, cysteine, thiol, amide, linear or ramified C1-C6 alkyl optionally substituted, primary or secondary amine, osidic derivative, lipid, phospholipid or cholesterol and said siRNA is selected to silence a target mRNA.
    Type: Grant
    Filed: April 26, 2004
    Date of Patent: April 7, 2009
    Assignee: Centre National de la Recherche Scientifique
    Inventors: Gilles Divita, May Catherine Morris, Frédéric Heitz, Federica Simeoni
  • Publication number: 20070129305
    Abstract: The present invention concerns cell-penetrating peptides which comprise an amino acid sequence consisting of GLX9WRAX9WRX1LX2RSLX9WX3X4X5X6X7X8 (SEQ ID No: 1), wherein X1 is A, L or G, X2 is W or none, X3 is R or K, X4 is K, L or S, X5 is L or K, X6 is R or W, X7 is K or S, and X8 is A, V or Q, and X9 is W, F or Y. These CPPs can be used as vectors for delivering nucleic acids and/or proteins and/or peptides to cells, in vitro or in vivo.
    Type: Application
    Filed: December 6, 2005
    Publication date: June 7, 2007
    Applicants: Centre National De La Recherche Scient., GENOSPECTRA, Inc.
    Inventors: Gilles Divita, Frederic Heitz, Catherine Morris, Gudrun Aldrian-Herrada
  • Publication number: 20050239687
    Abstract: Complex comprising a peptide carrier of SEQ ID NO:1 GALFLGFLGAAGSTMGAWSQPKR1KRKVR2 and an appropriate siRNA, wherein R1 represents any amino acid residue and more preferably K or S, R2 is null or represents one of the following groups: cysteamide, cysteine, thiol, amide, linear or ramified C1-C6 alkyl optionally substituted, primary or secondary amine, osidic derivative, lipid, phospholipid or cholesterol and said siRNA is selected to silence a target mRNA.
    Type: Application
    Filed: April 26, 2004
    Publication date: October 27, 2005
    Inventors: Gilles Divita, May Morris, Frederic Heitz, Federica Simeoni
  • Patent number: 6841535
    Abstract: Peptides that are useful as transfection agents are described. The peptides can facilitate the efficient cellular internalization of a broad range and size of compounds that when non-covalently complexed therewith are efficiently internalized into a cell. Advantages include but are not limited to excellent transfection efficiency, relatively low toxicity, internalization by a broad host cell spectrum, and the simplicity and cost-effectiveness that arise from not having to covalently complex the peptide with a specific molecule to be delivered. Applications include but are not limited to the delivery of diagnostics and therapeutics, as well as drug discovery, gene discovery, and the analysis and/or manipulation of other cellular and molecular biological functions. Claims are made for transfection agents, compositions of matter, including pharmaceutical compositions, reagent kits, methods of delivery, and methods of identification of additional peptides for performing and/or including in the same.
    Type: Grant
    Filed: July 26, 2001
    Date of Patent: January 11, 2005
    Assignees: Active Motif, Centre National de la Recherche Scientifique
    Inventors: Gilles Divita, May C. Morris, Jean Mery, Frederic Heitz, Joseph Fernandez, John Archdeacon, Kyle Horndorp
  • Publication number: 20030119725
    Abstract: Peptides that are useful as transfection agents are described. The peptides can facilitate the efficient cellular internalization of a broad range and size of compounds that when non-covalently complexed therewith are efficiently internalized into a cell. Advantages include but are not limited to excellent transfection efficiency, relatively low toxicity, internalization by a broad host cell spectrum, and the simplicity and cost-effectiveness that arise from not having to covalently complex the peptide with a specific molecule to be delivered. Applications include but are not limited to the delivery of diagnostics and therapeutics, as well as drug discovery, gene discovery, and the analysis and/or manipulation of other cellular and molecular biological functions. claims are made for transfection agents, compositions of matter, including pharmaceutical compositions, reagent kits, methods of delivery, and methods of identification of additional peptides for performing and/or including in the same.
    Type: Application
    Filed: July 26, 2001
    Publication date: June 26, 2003
    Inventors: Gilles Divita, May C. Morris, Jean Mery, Frederic Heitz, Joseph Fernandez, John Archdeacon, Kyle Hondorp